Is taking Veneclatra for 14 days a course of treatment?

VenetoclaxTaking 14 days is not a course of treatment. The treatment time is usually determined based on the patient's condition and other factors. You can consult the attending doctor for details. Veneclat is a BCL-2 inhibitor used to treat adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Venetoclax in combination with azacitidine, decitabine, or low-dose cytarabine in adults 75 years of age or older with newly diagnosed acute myeloid leukemia (AML) or with comorbidities that preclude the use of intensive induction chemotherapy.

In CLL/SLL, veneclat is most effective when used in combination with obinutuzumab or rituximab or alone. Common adverse reactions (≥20%) are neutropenia, thrombocytopenia, anemia, diarrhea, nausea, upper respiratory tract infection, cough, musculoskeletal pain, fatigue and edema. In AML, the most common adverse reactions when combined with azacitidine or decitabine or low-dose cytarabine (≥30%) For nausea, diarrhea, thrombocytopenia, constipation, neutropenia, febrile neutropenia, fatigue, vomiting, edema, pyrexia, pneumonia, dyspnea, bleeding, anemia, rash, abdominal pain, sepsis, musculoskeletal pain, dizziness, cough, oropharyngeal pain, and hypotension. The retail price of generic venetoclax100mg120 tablets ranges from 2 to 6 more than a thousand. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.

xa0